Willis K, Burt A
Proc Natl Acad Sci U S A. 2025; 122(6):e2414207122.
PMID: 39903106
PMC: 11831207.
DOI: 10.1073/pnas.2414207122.
Beltran A, Jiang X, Shen Y, Lehner B
Nature. 2025; 637(8047):885-894.
PMID: 39779847
PMC: 11754108.
DOI: 10.1038/s41586-024-08370-4.
DEsposito F, Zeppieri M, Cordeiro M, Capobianco M, Avitabile A, Gagliano G
Genes (Basel). 2025; 15(12.
PMID: 39766826
PMC: 11675667.
DOI: 10.3390/genes15121559.
Yang T, Kang E, Lin P, Yu B, Wang J, Chen V
Int J Mol Sci. 2024; 25(16).
PMID: 39201313
PMC: 11354650.
DOI: 10.3390/ijms25168626.
Nourmohammadi S, Henderson S, Ramesh S, Yool A
Biosci Rep. 2024; 44(8).
PMID: 39069912
PMC: 11358751.
DOI: 10.1042/BSR20240542.
-Associated Parkinson's Disease Is a Distinct Entity.
Skrahin A, Horowitz M, Istaiti M, Skrahina V, Lukas J, Yahalom G
Int J Mol Sci. 2024; 25(13).
PMID: 39000225
PMC: 11241486.
DOI: 10.3390/ijms25137102.
The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.
Gariballa N, Mohamed F, Badawi S, Ali B
J Biomed Sci. 2024; 31(1):64.
PMID: 38937821
PMC: 11210014.
DOI: 10.1186/s12929-024-01054-1.
Biochemical, structural, and computational analyses of two new clinically identified missense mutations of ALDH7A1.
Korasick D, Buckley D, Palpacelli A, Cursio I, Cesaroni E, Cheng J
Chem Biol Interact. 2024; 394:110993.
PMID: 38604394
PMC: 11073572.
DOI: 10.1016/j.cbi.2024.110993.
Heterozygous CAPZA2 mutations cause global developmental delay, hypotonia with epilepsy: a case report and the literature review.
Zhang X, Xu K, Kong J, Dong G, Dong S, Yang Z
J Hum Genet. 2024; 69(5):197-203.
PMID: 38374166
DOI: 10.1038/s10038-024-01230-z.
Phase separation as a possible mechanism for dosage sensitivity.
Yang L, Lyu J, Li X, Guo G, Zhou X, Chen T
Genome Biol. 2024; 25(1):17.
PMID: 38225666
PMC: 10789095.
DOI: 10.1186/s13059-023-03128-z.
OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets.
Wong D, Harvey J, Jurkute N, Thomasy S, Moosajee M, Yu-Wai-Man P
J Neuroophthalmol. 2023; 43(4):464-474.
PMID: 37974363
PMC: 10645107.
DOI: 10.1097/WNO.0000000000001830.
Dominance vs epistasis: the biophysical origins and plasticity of genetic interactions within and between alleles.
Xie X, Sun X, Wang Y, Lehner B, Li X
Nat Commun. 2023; 14(1):5551.
PMID: 37689712
PMC: 10492795.
DOI: 10.1038/s41467-023-41188-8.
Understanding structure-guided variant effect predictions using 3D convolutional neural networks.
Ramakrishnan G, Baakman C, Heijl S, Vroling B, van Horck R, Hiraki J
Front Mol Biosci. 2023; 10:1204157.
PMID: 37475887
PMC: 10354367.
DOI: 10.3389/fmolb.2023.1204157.
Buffering of genetic dominance by allele-specific protein complex assembly.
Badonyi M, Marsh J
Sci Adv. 2023; 9(22):eadf9845.
PMID: 37256959
PMC: 10413657.
DOI: 10.1126/sciadv.adf9845.
Impaired activity and membrane association of most calpain-5 mutants causal for neovascular inflammatory vitreoretinopathy.
Geddes J, Bondada V, Croall D, Rodgers D, Gal J
Biochim Biophys Acta Mol Basis Dis. 2023; 1869(6):166747.
PMID: 37207905
PMC: 10332796.
DOI: 10.1016/j.bbadis.2023.166747.
Spinocerebellar ataxia 38: structure-function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspot.
Ferrero E, Di Gregorio E, Ferrero M, Ortolan E, Moon Y, Di Campli A
Hum Genet. 2023; 142(8):1055-1076.
PMID: 37199746
PMC: 10449689.
DOI: 10.1007/s00439-023-02572-y.
Decoding hereditary spastic paraplegia pathogenicity through transcriptomic profiling.
Ho N, Chen X, Lei Y, Gu S
Zool Res. 2023; 44(3):650-662.
PMID: 37161652
PMC: 10236304.
DOI: 10.24272/j.issn.2095-8137.2022.281.
Mechanisms of Cyst Development in Polycystic Kidney Disease.
Qiu J, Germino G, Menezes L
Adv Kidney Dis Health. 2023; 30(3):209-219.
PMID: 37088523
PMC: 10289784.
DOI: 10.1053/j.akdh.2023.03.001.
Mendelian inheritance revisited: dominance and recessiveness in medical genetics.
Zschocke J, Byers P, Wilkie A
Nat Rev Genet. 2023; 24(7):442-463.
PMID: 36806206
DOI: 10.1038/s41576-023-00574-0.
Advances in gene therapy hold promise for treating hereditary hearing loss.
Jiang L, Wang D, He Y, Shu Y
Mol Ther. 2023; 31(4):934-950.
PMID: 36755494
PMC: 10124073.
DOI: 10.1016/j.ymthe.2023.02.001.